Home Industries Market Insights About Us Publisher Contact us

Cancer Microbiome Sequencing Market By Product Type (Kits, Assays, Software, Services) By Technology (Next-Generation Sequencing (Sequencing by Synthesis, Sequencing by Ligation, and Other Next-Generation Sequencing Technologies), Polymerase Chain Reaction) By End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories) - Global Opportunity Analysis And Industry Forecast, 2021-2027

Categories: Life Science

Formate :

Global Cancer Microbiome Sequencing Market Overview

The Global Cancer Microbiome Sequencing Market size is estimated to reach $1038.1 Million by 2026, growing at a CAGR of 5.4% over the forecast period of 2021-2026.

 

The human microbiome is a collection of bacteria that dwell in and on the human body that can influence cancer start, progression, and treatment response, including cancer immunotherapy. Microbiomes' effects on cancer might lead to new diagnostics and therapies. It defines the field of the Cancer Microbiome Sequencing Market. The key market drivers in this market are Increasing Emphasis on the Microbiome's Potential in the Field of Cancer, Global Increase in Cancer Prevalence, Decreasing Cost of Sequencing.

 

Impact of COVID-19 on Cancer Microbiome Sequencing Market:

The lung microbiome was discovered to significantly influence the severity of the disease and susceptibility to the SARS-CoV-2 infection in 2020. The lung microbiome also plays a key role in the formation of immune responses to viral infection, and the microbiome may impact COVID-19's prognosis. As a result, increased research investigations in the microbiome field are significant drivers of market expansion.

 

Key Takeaways from Global Cancer Microbiome Sequencing Market Report:

  • Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units), and Value ($M) data given at country level – for a product, end-use, technology and by different industry verticals. Understand the different market dynamics – key driving factors, challenges, and hidden opportunities.
  • Get in-depth insights on your competitor's performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
  • Analyze the sales and distribution channels across key geographies to improve top-line revenues.
  • Understand the industry supply chain with a deep dive on the value augmentation at each step to optimize value and bring efficiencies in your processes.
  • Get a quick outlook on the market entropy – M&As, deals, partnerships, product launches of all key players for the past 4 years.
  • Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than the top 20 countries globally for the market.

 

By End User, the market for Academic and Research Institutes is estimated to grow at the highest CAGR during the forecast period.

By End User, Hospitals and Diagnostic Laboratories dominated the market in 2020 owing to a maximum number of sequencing tests conducted in laboratories to detect various diseases. However, Academic and Research Institutes is set to be the fastest-growing over the period 2021-2016, with a CAGR of 6.1%. It is owing to the increasing number of research done to get details of the microbiome at a more complex level.

 

The Asia Pacific to account for the largest market share during the forecast period

Due to the presence of market leaders like Illumina, Inc. in the United States and the widespread use of high-fidelity cancer microbiome sequencing products and services for translational research, North America has the biggest share of the cancer microbiome sequencing market. Furthermore, higher federal money infusions and increased product development spending, among other things. Apart from that, throughout the projection period of 2021-2031, the Asia-Pacific region is expected to develop at the quickest CAGR. It can be linked to many causes, including increased healthcare knowledge, a stable economy that encourages more research, and broad acceptance of modern cancer diagnostics, to name a few.

 

Market Dynamics

Driver:

  • Global Increase in Cancer Prevalence drives the market demand

In 2020, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) will be diagnosed worldwide, with around 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer).

 

Challenge:

There are regulatory challenges associated with this particular field as it involves complicated healthcare impacts to be addressed while getting regulatory approvals.

 

Key Market Players:

Key Players in Global Cancer Microbiome Sequencing Market consist of Illumina, Inc.*, Thermo Fisher Scientific Inc., Viome, Inc., Novogene Corporation, Psomagen, Inc, PerkinElmer Genomics, PerkinElmer Genomics, Invivo Diagnostics, Zymo Research Corp, Metabiomics, among others.

 

Developments:

  • There have been no developments in the Cancer Microbiome Sequencing Market in the last 5 years.

 

Report Coverage and Scope:

The report "Global Cancer Microbiome Sequencing Market" by Research Informatic covers an in-depth, detailed analysis of the following segments, which are covered under the scope.

 

By Product

  • Kits
  • Assays
  • Software
  • Services

 

By End Users

  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Diagnostic Laboratories

 

By Technology

  • Next-Generation Sequencing (Sequencing by Synthesis, Sequencing by Ligation, and Other Next-Generation Sequencing Technologies)
  • Polymerase Chain Reaction

 

Geography

  • North America
  • Europe
  • APAC
  • RoW

Chapter 1 Cancer Microbiome Sequencing Market Overview


 


1.1 Product Overview and Scope of Cancer Microbiome Sequencing


1.2 Cancer Microbiome Sequencing Market Segmentation By Product Type


1.2.1 Kits


1.2.2 Assays


1.2.3 Software


1.2.4 Services


1.3 Cancer Microbiome Sequencing Market Segmentation By End User


1.3.1 Academic and Research Institutes


1.3.2 Pharmaceutical and Biotechnology Companies


1.3.3 Hospitals and Diagnostic Laboratories


1.4 Cancer Microbiome Sequencing Market Segmentation by Regions


1.4.1 North America


1.4.2 China


1.4.3 Europe


1.4.4 Southeast Asia


1.4.5 Japan


1.4.6 India


1.5 Global Market Size (Value) of Cancer Microbiome Sequencing (2015-2027)


 


Chapter 2 Global Economic Impact on Cancer Microbiome Sequencing Industry


 


2.1 Global Macroeconomic Environment Analysis


2.1.1 Global Macroeconomic Analysis


2.1.2 Global Macroeconomic Environment Development Trend


2.2 Global Macroeconomic Environment Analysis by Regions


 


Chapter 3 Global Cancer Microbiome Sequencing Market Competition by Manufacturers


 


3.1 Global Cancer Microbiome Sequencing Production and Share by Manufacturers (2021 and 2021)


3.2 Global Cancer Microbiome Sequencing Revenue and Share by Manufacturers (2021 and 2021)


3.3 Global Cancer Microbiome Sequencing Average Price by Manufacturers (2021 and 2021)


3.4 Manufacturers Cancer Microbiome Sequencing Manufacturing Base Distribution, Production Area and Product Type


3.5 Cancer Microbiome Sequencing Market Competitive Situation and Trends


3.5.1 Cancer Microbiome Sequencing Market Concentration Rate


3.5.2 Cancer Microbiome Sequencing Market Share of Top 3 and Top 5 Manufacturers


3.5.3 Mergers & Acquisitions, Expansion


 


 Chapter 4 Global Cancer Microbiome Sequencing Production, Revenue (Value) by Region (2015-2021)


 


4.1 Global Cancer Microbiome Sequencing Production by Region (2015-2021)


4.2 Global Cancer Microbiome Sequencing Production Market Share by Region (2015-2021)


4.3 Global Cancer Microbiome Sequencing Revenue (Value) and Market Share by Region (2015-2021)


4.4 Global Cancer Microbiome Sequencing Production, Revenue, Price and Gross Margin (2015-2021)


4.5 North America Cancer Microbiome Sequencing Production, Revenue, Price and Gross Margin (2015-2021)


4.6 Europe Cancer Microbiome Sequencing Production, Revenue, Price and Gross Margin (2015-2021)


4.7 China Cancer Microbiome Sequencing Production, Revenue, Price and Gross Margin (2015-2021)


4.8 Japan Cancer Microbiome Sequencing Production, Revenue, Price and Gross Margin (2015-2021)


4.9 Southeast Asia Cancer Microbiome Sequencing Production, Revenue, Price and Gross Margin (2015-2021)


4.10 India Cancer Microbiome Sequencing Production, Revenue, Price and Gross Margin (2015-2021)


 


Chapter 5 Global Cancer Microbiome Sequencing Supply (Production), Consumption, Export, Import by Regions (2015-2021)


 


5.1 Global Cancer Microbiome Sequencing Consumption by Regions (2015-2021)


5.2 North America Cancer Microbiome Sequencing Production, Consumption, Export, Import by Regions (2015-2021)


5.3 Europe Cancer Microbiome Sequencing Production, Consumption, Export, Import by Regions (2015-2021)


5.4 China Cancer Microbiome Sequencing Production, Consumption, Export, Import by Regions (2015-2021)


5.5 Japan Cancer Microbiome Sequencing Production, Consumption, Export, Import by Regions (2015-2021)


5.6 Southeast Asia Cancer Microbiome Sequencing Production, Consumption, Export, Import by Regions (2015-2021)


5.7 India Cancer Microbiome Sequencing Production, Consumption, Export, Import by Regions (2015-2021)


 


 Chapter 6 Global Cancer Microbiome Sequencing Production, Revenue (Value), Price Trend by Type


 


6.1 Global Cancer Microbiome Sequencing Production and Market Share by Type (2015-2021)


6.2 Global Cancer Microbiome Sequencing Revenue and Market Share by Type (2015-2021)


6.3 Global Cancer Microbiome Sequencing Price by Type (2015-2021)


6.4 Global Cancer Microbiome Sequencing Production Growth by Type (2015-2021)


 


Chapter 7 Global Cancer Microbiome Sequencing Market Analysis by Application


 


7.1 Global Cancer Microbiome Sequencing Consumption and Market Share by Application (2015-2021)


7.2 Global Cancer Microbiome Sequencing Consumption Growth Rate by Application (2015-2021)


7.3 Market Drivers and Opportunities


7.3.1 Potential Applications


7.3.2 Emerging Markets/Countries


 


Chapter 8 Cancer Microbiome Sequencing Manufacturing Cost Analysis


8.1 Cancer Microbiome Sequencing Key Raw Materials Analysis


8.1.1 Key Raw Materials


8.1.2 Price Trend of Key Raw Materials


8.1.3 Key Suppliers of Raw Materials


8.1.4 Market Concentration Rate of Raw Materials


8.2 Proportion of Manufacturing Cost Structure


8.2.1 Raw Materials


8.2.2 Labour Cost


8.2.3 Manufacturing Expenses


8.3 Manufacturing Process Analysis of Cancer Microbiome Sequencing


 


Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers


 


9.1 Cancer Microbiome Sequencing Industrial Chain Analysis


9.2 Upstream Raw Materials Sourcing


9.3 Raw Materials Sources of Cancer Microbiome Sequencing Major Manufacturers in 2021


9.4 Downstream Buyers


 


Chapter 10 Marketing Strategy Analysis, Distributors/Traders


 


10.1 Marketing Channel


10.1.1 Direct Marketing


10.1.2 Indirect Marketing


10.1.3 Marketing Channel Development Trend


10.2 Market Positioning


10.2.1 Pricing Strategy


10.2.2 Brand Strategy


10.2.3 Target Client


10.3 Distributors/Traders List


 


Chapter 11 Market Effect Factors Analysis


 


11.1 Technology Progress/Risk


11.1.1 Substitutes Threat


11.1.2 Technology Progress in Related Industry


11.2 Consumer Needs/Customer Preference Change


11.3 Economic/Political Environmental Change


 


Chapter 12 Global Cancer Microbiome Sequencing Market Forecast (2021-2027)


 


12.1 Global Cancer Microbiome Sequencing Production, Revenue Forecast (2021-2027)


12.2 Global Cancer Microbiome Sequencing Production, Consumption Forecast by Regions (2021-2027)


12.3 Global Cancer Microbiome Sequencing Production Forecast by Type (2021-2027)


12.4 Global Cancer Microbiome Sequencing Consumption Forecast by Application (2021-2027)


12.5 Cancer Microbiome Sequencing Price Forecast (2021-2027)


 


Chapter 13 Appendix    

Request For Methodology

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

Request For List Of Tables

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

FAQ

What Is The Microbiome Sequencing Market?

The human microbiome is a collection of bacteria that dwell in and on the human body that can influence cancer start, progression, and treatment response, including cancer immunotherapy. Microbiomes' effects on cancer might lead to new diagnostics and therapies. It defines the field of the Cancer Microbiome Sequencing Market. The key market drivers in this market are Increasing Emphasis on the Microbiome's Potential in the Field of Cancer, Global Increase in Cancer Prevalence, Decreasing Cost of Sequencing.

Is The Cancer Sequencing Industry Growing?

The Global Cancer Microbiome Sequencing Market is growing at a CAGR of 5.4% over the forecast period of 2021-2026.

How Big Is The Microbiome Sequencing Market?

The Global Cancer Microbiome Sequencing Market size is estimated to reach $1038.1 Million by 2026.

Which Are The Top Drone Delivery Companies Operating In Industry?

Key Players in Global Cancer Microbiome Sequencing Market consist of Illumina, Inc., Thermo Fisher Scientific Inc., Viome, Inc., Novogene Corporation, Psomagen, Inc, PerkinElmer Genomics, PerkinElmer Genomics, Invivo Diagnostics, Zymo Research Corp, Metabiomics, among others.

Choose License Type

Single User

US$ 3500

Multi User

US$ 5250

Corporate User

US$ 7000

Personalize this Research

  • Market Size and Share from 2016 - 2027
  • Expected Market Growth Until 2027
  • COVID-19 Impact assessment on the market
  • Market Dynamics and Impact Analysis
  • Segment and region that will drive or lead the market growth and why
  • Industry activity comprising Mergers, Acquisitions, Expansion, etc.
  • Comprehensive Mapping of the Competitive Landscape
  • In-depth analysis of key sustainability strategies adopted by market players
  • Global and regional market trends – Current and Future
  • Value Chain Analysis
  • Porters Five Forces Analysis
  • Historical and Current Product Pricing
  • Country Cross-Segment Analysis
  • Company Profiling
  • Player Comparison Matrix

Life Science Clients

Cancer Microbiome Sequencing Market By Product Typ...

RD Code : HP21